Anavex Life Sciences Corp (AVXL)

[Gator328]

Most likely there will be a slight run-up prior to CTAD and then the stock will fade down in classic "sell the news" fashion. Even with positive P3 data, there's still an enormous amount of time between releasing the top line report and meeting with the FDA and with a shaky market sentiment, I can easily see the share price dropping until the FDA makes a decision. The intrinsic value we're all banking on won't be realized until the company becomes profitable and we're still a few years away from that happening. The good news is that with a positive showing at CTAD, the 7+ years investment many longs have endured will finally become significantly de-risked and we'll start to see money that's been on the sidelines flowing into this former printing company.

I'd expect a few hit pieces as well to trickle out after CTAD, dampening some of the excitement surrounding positive data. This is just a speed bump but experienced investors and institutions who were too risk averse to invest early will want to acquire shares as cheaply as possible.

I'm still holding some shares in a shoebox in my closet. The next few months will be interesting but I don't think the weeks immediately after December 1st will result in the share price appreciation many here are talking about. In my opinion, we're looking at late 2023 / early 2024 for Anavex stock to make its big move.